Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the breadcrumb-navxt domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /sites/stg.balchem.matchbox.host/files/wp-includes/functions.php on line 6114

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the media-library-assistant domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /sites/stg.balchem.matchbox.host/files/wp-includes/functions.php on line 6114
migrate Archives - Page 3 of 4 - Balchem
July 29, 2022

Balchem Corporation Reports Second Quarter 2022 Financial Results

Ted Harris, Chairman, CEO, and President of Balchem said, “The second quarter of 2022 was another excellent quarter for Balchem. We delivered very strong financial results with record sales and adjusted EBITDA in what remains a very difficult macro-economic and geo-political environment."
July 15, 2022

Balchem Announces Conference Call for Second Quarter 2022 Financial Results

Join Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO on Friday, July 29th at 11:00 AM Eastern Time (ET) to review 2nd Quarter 2022 results.
June 21, 2022

Balchem Corporation Completes Acquisition of Kappa Bioscience AS

We are excited to announce that we completed our acquisition of Kappa Bioscience AS, a leading science-based manufacturer of specialty vitamin K2 for the human nutrition industry, headquartered in Oslo, Norway.
June 14, 2022

Balchem Corporation Signs Definitive Agreement to Acquire Kappa Bioscience AS

Balchem has signed a definitive agreement to acquire Kappa Bioscience AS, a leading science-based manufacturer of specialty vitamin K2 for the human nutrition industry, headquartered in Oslo, Norway.
April 29, 2022

Balchem Corporation Reports First Quarter 2022 Financial Results

Ted Harris, Chairman, CEO, and President of Balchem said, “We are very pleased to have continued the strong momentum from 2021 into 2022. In the first quarter of 2022 we delivered all-time record sales, adjusted net earnings, and adjusted EBITDA in a very difficult macro-economic and geo-political environment.”
April 22, 2022

Balchem Releases 2021 Sustainability Report

Balchem Corporation today released its 2021 Sustainability Report, which captures the Company's commitment to managing our Environmental, Social and Governance (ESG) performance.
April 15, 2022

Balchem Announces Conference Call for First Quarter 2022 Financial Results

Join Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO on Friday, April 29th at 11:00 AM Eastern Time (ET) to review 1st Quarter 2022 results.
January 18, 2022

Balchem Corporation Named on Newsweek’s 2022 List of America’s Most Responsible Companies

Balchem named one of America's Most Responsible Companies by Newsweek magazine for the second consecutive year.
December 16, 2021

Balchem Announces Dividend

Ted Harris, Balchem’s CEO and President, said, “Balchem has a long-standing commitment to an annual dividend and we are pleased to announce the continuation of that commitment."
April 26, 2021

Balchem Releases 2020 Sustainability Report

Balchem Corporation today released its 2020 Sustainability Report, which captures the Company’s commitment to managing our Environmental, Social and Governance …
December 17, 2020

Balchem Corporation Announces Dividend

Balchem declares a dividend on its shares of common stock equal to $0.58 per share which represents the eleventh consecutive increase.
September 15, 2020

Balchem Corporation to Present at the Sidoti Fall 2020 Virtual Investor Conference on September 23rd, 2020

Balchem Corporation (NASDAQ: BCPC) Chairman of the Board, Chief Executive Officer, and President Ted Harris and Chief Financial Officer Martin …
1 2 3 4
Page 3 of 4